Clinical Trial Update: Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of Aminocamptothecin in patients with advanced cancer of the peritoneal cavity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer of the Peritoneum
• Peritoneal Cancer

Drugs mentioned

• Aminocamptothecin (aminocamptothecin)

Snippet

Sponsor: NYU Langone Health | Conditions: Cancer | Phase 1 | Status: COMPLETED